Novonesis to acquire Feed Enzyme Alliance from dsm-firmenich for $1.5bn.

Novonesis, a global biosolutions company, agreed to acquire Feed Enzyme Alliance from dsm-firmenich, a multinational corporation active in the fields of health, nutrition and materials., for $1.5bn. “We are thrilled to announce the strategic acquisition of the full Feed Enzyme Alliance. Growing global protein demand, coupled with increasing land and water scarcity, requires innovative solutions. Now with an expanded presence across the animal biosolutions value chain, we are better positioned to create more value for customers with sustainable value adding biosolutions. This transaction underscores our commitment to driving growth, while also improving our EBITDA margin," Ester Baiget, Novonesis CEO.